Tenax Therapeutics, Inc.
TENXNasdaqCIK 34956HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | 0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | 0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-13, accession 0000950170-25-108063. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001193125-25-277793. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | 0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001193125-26-327455. Derived: 6-month figure less the 3-month figure.Report this figure |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | 1.1Research and development, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001654954-24-014262.Report this figure | 1.7Research and development, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-25, accession 0000950170-25-044398. Derived: 12-month figure less the 9-month figure.Report this figure | 2.7Research and development, Q1 FY2024, three months to 2024-03-31$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | 2.3Research and development, Q2 FY2024, three months to 2024-06-30$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | 3.1Research and development, Q3 FY2024, three months to 2024-09-30$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 4.6Research and development, Q4 FY2024, three months to 2024-12-31$4.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | 5.7Research and development, Q1 FY2025, three months to 2025-03-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | 6.1Research and development, Q2 FY2025, three months to 2025-06-30$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 10.3Research and development, Q3 FY2025, three months to 2025-09-30$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 10.5Research and development, Q4 FY2025, three months to 2025-12-31$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | 11.5Research and development, Q1 FY2026, three months to 2026-03-31$11.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | 12.9Research and development, Q2 FY2026, three months to 2026-06-30$12.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | 5.7Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$5.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | not reported | not reported | not reported | 5.9Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$5.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Operating income | $m | 2.1Operating income, Q3 FY2023, three months to 2023-09-30$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001654954-24-014262.Report this figure | (13.1)Operating income, Q4 FY2023, three months to 2023-12-31−$13.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044398. Derived: 12-month figure less the 9-month figure.Report this figure | (3.9)Operating income, Q1 FY2024, three months to 2024-03-31−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | (3.7)Operating income, Q2 FY2024, three months to 2024-06-30−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | (4.6)Operating income, Q3 FY2024, three months to 2024-09-30−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | (7.3)Operating income, Q4 FY2024, three months to 2024-12-31−$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | (11.3)Operating income, Q1 FY2025, three months to 2025-03-31−$11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | (11.8)Operating income, Q2 FY2025, three months to 2025-06-30−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | (16.8)Operating income, Q3 FY2025, three months to 2025-09-30−$16.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | (16.4)Operating income, Q4 FY2025, three months to 2025-12-31−$16.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | (16.6)Operating income, Q1 FY2026, three months to 2026-03-31−$16.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | (18.8)Operating income, Q2 FY2026, three months to 2026-06-30−$18.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Interest expense | $m | 0.0Interest expense, Q3 FY2023, three months to 2023-09-30$5.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-13, accession 0001654954-24-014262.Report this figure | 0.0Interest expense, Q4 FY2023, three months to 2023-12-31$2.2k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-25, accession 0000950170-25-044398. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Interest expense, Q1 FY2024, three months to 2024-03-31$8.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | 0.0Interest expense, Q2 FY2024, three months to 2024-06-30$9.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | 0.0Interest expense, Q3 FY2024, three months to 2024-09-30$7.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | (0.0)Interest expense, Q4 FY2024, three months to 2024-12-31−$1.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | 2.0Net income, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001654954-24-014262.Report this figure | (12.2)Net income, Q4 FY2023, three months to 2023-12-31−$12.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044398. Derived: 12-month figure less the 9-month figure.Report this figure | (3.8)Net income, Q1 FY2024, three months to 2024-03-31−$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | (3.6)Net income, Q2 FY2024, three months to 2024-06-30−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | (4.0)Net income, Q3 FY2024, three months to 2024-09-30−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | (6.3)Net income, Q4 FY2024, three months to 2024-12-31−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | (10.4)Net income, Q1 FY2025, three months to 2025-03-31−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | (10.8)Net income, Q2 FY2025, three months to 2025-06-30−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | (15.8)Net income, Q3 FY2025, three months to 2025-09-30−$15.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | (15.5)Net income, Q4 FY2025, three months to 2025-12-31−$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | (15.7)Net income, Q1 FY2026, three months to 2026-03-31−$15.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | (17.8)Net income, Q2 FY2026, three months to 2026-06-30−$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Diluted EPS | $ per share | not reported | not reported | (3.12)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$3.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | (1.83)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | (0.19)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | not reported | (0.28)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | (0.27)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | (0.40)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | not reported | (0.35)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | (0.35)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Basic EPS | $ per share | not reported | not reported | (3.12)Basic EPS, Q1 FY2024, three months to 2024-03-31−$3.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | (1.83)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | (0.19)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | not reported | (0.28)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | (0.27)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | (0.40)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | not reported | (0.35)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | (0.35)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 0.3Cash and equivalents, Q3 FY2023, at 2023-09-30$345.0k. XBRL concept us-gaap:Cash. 10-Q filed 2023-11-13, accession 0001654954-23-014168.Report this figure | 9.8Cash and equivalents, FY2023, at 2023-12-31$9.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-25, accession 0000950170-25-044398.Report this figure | not reported | not reported | not reported | 94.9Cash and equivalents, FY2024, at 2024-12-31$94.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001193125-26-099393.Report this figure | 111Cash and equivalents, Q1 FY2025, at 2025-03-31$111.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | 106Cash and equivalents, Q2 FY2025, at 2025-06-30$105.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | 99.4Cash and equivalents, Q3 FY2025, at 2025-09-30$99.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 97.6Cash and equivalents, FY2025, at 2025-12-31$97.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001193125-26-099393.Report this figure | 119Cash and equivalents, Q1 FY2026, at 2026-03-31$118.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | 118Cash and equivalents, Q2 FY2026, at 2026-06-30$118.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Current assets | $m | 11.9Current assets, Q3 FY2023, at 2023-09-30$11.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001654954-23-014168.Report this figure | 11.7Current assets, FY2023, at 2023-12-31$11.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-25, accession 0000950170-25-044398.Report this figure | 14.5Current assets, Q1 FY2024, at 2024-03-31$14.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001654954-24-006228.Report this figure | 10.6Current assets, Q2 FY2024, at 2024-06-30$10.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001654954-24-010456.Report this figure | 99.8Current assets, Q3 FY2024, at 2024-09-30$99.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001654954-24-014262.Report this figure | 96.7Current assets, FY2024, at 2024-12-31$96.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099393.Report this figure | 112Current assets, Q1 FY2025, at 2025-03-31$112.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | 106Current assets, Q2 FY2025, at 2025-06-30$105.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | 103Current assets, Q3 FY2025, at 2025-09-30$102.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 104Current assets, FY2025, at 2025-12-31$104.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 123Current assets, Q1 FY2026, at 2026-03-31$123.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | 122Current assets, Q2 FY2026, at 2026-06-30$121.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Total assets | $m | 11.9Total assets, Q3 FY2023, at 2023-09-30$11.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001654954-23-014168.Report this figure | 11.7Total assets, FY2023, at 2023-12-31$11.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-25, accession 0000950170-25-044398.Report this figure | 14.5Total assets, Q1 FY2024, at 2024-03-31$14.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001654954-24-006228.Report this figure | 10.6Total assets, Q2 FY2024, at 2024-06-30$10.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001654954-24-010456.Report this figure | 99.8Total assets, Q3 FY2024, at 2024-09-30$99.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001654954-24-014262.Report this figure | 96.7Total assets, FY2024, at 2024-12-31$96.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001193125-26-099393.Report this figure | 112Total assets, Q1 FY2025, at 2025-03-31$112.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | 106Total assets, Q2 FY2025, at 2025-06-30$105.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | 103Total assets, Q3 FY2025, at 2025-09-30$102.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 104Total assets, FY2025, at 2025-12-31$104.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 123Total assets, Q1 FY2026, at 2026-03-31$123.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | 122Total assets, Q2 FY2026, at 2026-06-30$121.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Current liabilities | $m | 0.6Current liabilities, Q3 FY2023, at 2023-09-30$602.2k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001654954-23-014168.Report this figure | 3.6Current liabilities, FY2023, at 2023-12-31$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-25, accession 0000950170-25-044398.Report this figure | 2.0Current liabilities, Q1 FY2024, at 2024-03-31$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001654954-24-006228.Report this figure | 1.7Current liabilities, Q2 FY2024, at 2024-06-30$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001654954-24-010456.Report this figure | 2.6Current liabilities, Q3 FY2024, at 2024-09-30$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001654954-24-014262.Report this figure | 4.7Current liabilities, FY2024, at 2024-12-31$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099393.Report this figure | 2.8Current liabilities, Q1 FY2025, at 2025-03-31$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | 2.5Current liabilities, Q2 FY2025, at 2025-06-30$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | 6.6Current liabilities, Q3 FY2025, at 2025-09-30$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 7.2Current liabilities, FY2025, at 2025-12-31$7.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 8.5Current liabilities, Q1 FY2026, at 2026-03-31$8.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | 8.1Current liabilities, Q2 FY2026, at 2026-06-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Total liabilities | $m | 0.6Total liabilities, Q3 FY2023, at 2023-09-30$602.2k. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001654954-23-014168.Report this figure | 3.6Total liabilities, FY2023, at 2023-12-31$3.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-25, accession 0000950170-25-044398.Report this figure | 2.0Total liabilities, Q1 FY2024, at 2024-03-31$2.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001654954-24-006228.Report this figure | 1.7Total liabilities, Q2 FY2024, at 2024-06-30$1.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001654954-24-010456.Report this figure | 2.6Total liabilities, Q3 FY2024, at 2024-09-30$2.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001654954-24-014262.Report this figure | 4.7Total liabilities, FY2024, at 2024-12-31$4.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001193125-26-099393.Report this figure | 2.8Total liabilities, Q1 FY2025, at 2025-03-31$2.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | 2.5Total liabilities, Q2 FY2025, at 2025-06-30$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0000950170-25-108063.Report this figure | 6.6Total liabilities, Q3 FY2025, at 2025-09-30$6.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 7.2Total liabilities, FY2025, at 2025-12-31$7.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 8.5Total liabilities, Q1 FY2026, at 2026-03-31$8.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | 8.1Total liabilities, Q2 FY2026, at 2026-06-30$8.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
| Shareholders' equity | $m | 11.3Shareholders' equity, Q3 FY2023, at 2023-09-30$11.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001654954-24-014262.Report this figure | 8.1Shareholders' equity, FY2023, at 2023-12-31$8.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001193125-26-099393.Report this figure | 12.4Shareholders' equity, Q1 FY2024, at 2024-03-31$12.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 8.9Shareholders' equity, Q2 FY2024, at 2024-06-30$8.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 97.2Shareholders' equity, Q3 FY2024, at 2024-09-30$97.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 92.0Shareholders' equity, FY2024, at 2024-12-31$92.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 109Shareholders' equity, Q1 FY2025, at 2025-03-31$109.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 103Shareholders' equity, Q2 FY2025, at 2025-06-30$103.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 96.2Shareholders' equity, Q3 FY2025, at 2025-09-30$96.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277793.Report this figure | 97.1Shareholders' equity, FY2025, at 2025-12-31$97.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 115Shareholders' equity, Q1 FY2026, at 2026-03-31$114.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure | 114Shareholders' equity, Q2 FY2026, at 2026-06-30$113.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001193125-26-327455.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (2.1)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001654954-24-014262. Derived: 9-month figure less the 6-month figure.Report this figure | (1.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-25, accession 0000950170-25-044398. Derived: 12-month figure less the 9-month figure.Report this figure | (5.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$5.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-071395.Report this figure | (3.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0000950170-25-108063. Derived: 6-month figure less the 3-month figure.Report this figure | (3.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277793. Derived: 9-month figure less the 6-month figure.Report this figure | (3.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | (7.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | (6.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001193125-26-327455. Derived: 6-month figure less the 3-month figure.Report this figure | (9.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277793. Derived: 9-month figure less the 6-month figure.Report this figure | (13.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099393. Derived: 12-month figure less the 9-month figure.Report this figure | (9.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219383.Report this figure | (14.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$14.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001193125-26-327455. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
Shares
| Line item | Unit | Q3 FY20142014-01-31 | Q1 FY20152014-07-31 | Q2 FY20152014-10-31 | Q3 FY20152015-01-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 10.3 | 27.7 | 28.1 | 28.1 | 1.2 | 2.0 | 21.2 | 36.6 | 39.6 | 39.7 | 45.2 | 50.9 |
Shares outstanding: 37.42m at Jul 28, 2026, from the cover of the 10-Q filed Jul 31, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. Listed shows no prices and gives no investment advice.